Generic Drug Tariffs Could Raise US Medicine Costs

Original Article by Amber Tong and Laura Curtis Bloomberg | 22 July 2026

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

AI Image | Chat-GPT

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.